NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Novel Microdevices

Novel Microdevices

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://noveldx.com/

Last Round

Seed Round

Apr 27, 2026

Total Funding Raised

$24.26M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Novel Microdevices is a diagnostic equipment company that develops a handheld point-of-care medical device designed to facilitate molecular diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Keywords

point-of-care diagnosticsmolecular diagnosticsPOC testingmicrofluidic cartridgesRT-PCRNAATnucleic acid amplificationrapid infectious disease testingportable diagnostic systemsample-to-answerlab-on-a-chipdiagnostic consumablesrazor-and-blade modelclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novel Microdevices Comps

Public and private peers based on sector, stage, and business model.

Novel Microdevices comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Novel Microdevices Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 27, 2026
GrantJun 19, 2025
VC RoundFeb 18, 2025
Early FundingFeb 18, 2025
GrantNov 8, 2024
Grant
Aug 7, 2023

Key People

Founding team and executive leadership

Andrea Pais

Founder And CEO

Founding Team

Joseph Swiader

Advisor To The Chief Executive Officer

Executive Team

Carlos L. Aparicio

COO

Executive Team

Novel Microdevices Investors

Notable investors and investment history

Novel Microdevices investors
InvestorRounds
CARB-XGrant
NIH RADxGrant
TEDCOSeries A, Early Funding, VC Round, Pre Seed
Maryland Department of CommerceGrant
Old Line Capital PartnersSeries A
National Institutes of Health (NIH)Grant
Ecphora CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    $1M raised in Seed Round.

Novel Microdevices Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Novel Microdevices Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novel Microdevices's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range45
Year Founded2015
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.